Urgent

Diuretics in the ICU

Diuresis · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Loop diuretics (furosemide/bumetanide) for volume overload — they treat congestion, NOT oliguria of hypovolaemia, and do not prevent or treat AKI itself; thiazide (metolazone) synergy for loop resistance; spironolactone in chronic heart failure/cirrhotic ascites; mannitol/hypertonic saline are osmotherapy, not “renal protection”.

Red flags

  • Furosemide for low urine output in an under-filled patient deepens the AKI
  • A “good diuresis” that drops the BP has moved the problem, not solved it

Management

  • First ask: is the oliguria WET or DRY? A fluid-responsiveness assessment precedes every furosemide dose in shock
  • Target a measurable endpoint: net negative balance/day, weight, oxygenation — not “urine happened”
  • Loop resistance: confirm delivery (albumin-bound drug needs GFR), double the dose before shortening the interval, add thiazide, then accept RRT for the truly overloaded failing kidney
  • Watch the chemistry: hypokalaemia, hypomagnesaemia, alkalosis, ototoxicity at high infusion rates
  • De-resuscitation of the recovering MODS patient (drip-and-suck out the accumulated litres) improves ventilation and mobility — protocolise it

Drugs & doses

Furosemide 20–80 mg IV boluses or 5–10 mg/h infusion (high doses in renal impairment)
Metolazone 2.5–5 mg PO 30 min before the loop dose (sequential blockade)
Spironolactone 100–400 mg/day in ascites (watch K⁺)
Acetazolamide 250–500 mg for metabolic alkalosis with overload

Diuretics treat congestion with an endpoint — they are not kidney medicine.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.